The invention relates to compositions containing a chitosan oligosaccharide and at least one pharmaceutical product. Said compositions allow active ingredients to be administered transdermally to patients. As the gastrointestinal tract is bypassed, side effects can be prevented. In addition, a synergistic action can be observed.